Michael Honigberg: Clonal Hematopoiesis as a Driver of Aortic Valve Calcification
Michael Honigberg, Associate Professor of Medicine at Harvard Medical School, Associate Editor at Journal of the American College of Cardiology (JACC), shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cardiovascular Medicine, adding:
“Excited to share our new preprint – a highly collaborative effort integrating population genomics, cardiac imaging, and experimental biology, led by Aeron Small with the Trevor Fidler and Elena Aikawa labs.
We found that ASXL1-mutant clonal hematopoiesis (CHIP) was associated with incident aortic stenosis and worse aortic valve hemodynamics.
In complementary experiments, ASXL1-mutant macrophage-like cells produced a pro-inflammatory secretome and accelerated calcification in human valve cells, a response blunted by IL-1 or IL-6 inhibition.
Grateful to co-authors and collaborators including Liying Xue, Shinsuke Ito, Cesar De Jeronimo, Sasha A. Singh, Mesbah Uddin, Art Schuermans, Spencer Flynn, George Thanassoulis, Peter Libby, Amil Shah, Christie Ballantyne, Pradeep Natarajan.”
Title: ASXL1-Mutant Clonal Hematopoiesis is Associated with Calcific Aortic Valve Disease and Promotes Valvular Calcification In Vitro
Authors: Aeron Small, Liying Xue, Shinsuke Ito, Cesar De Jeronimo Diaz, Yuto Nakamura, Niekbachsh Mohammadnia, Huajun Liao, Yota Maekawa, Linke Li, Sasha A Singh, Taku Kasai, Luisa Weiss, Md Mesbah Uddin, Art Schuermans, Spencer Flynn, Elby Mackenzie, James C Engert, George Thanassoulis, Peter Libby, Amil Shah, Christie M. Ballantyne, Pradeep Natarajan, Trevor Fidler, Elena Aikawa, Michael C. Honigberg

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines